• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

63.79 -0.70 (-1.09%)
Streaming Delayed Price Updated: 11:16 AM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 198,404
Open 65.27
Bid (Size) 63.76 (300)
Ask (Size) 63.83 (200)
Prev. Close 64.49
Today's Range 63.68 - 65.28
52wk Range 47.50 - 82.22
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm
April 21, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
3 Cash-Producing Stocks with Exciting Potential
April 10, 2026
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain ... 
Via StockStory

Performance

YTD
-9.3%
-9.3%
1 Month
+2.7%
+2.7%
3 Month
-8.7%
-8.7%
6 Month
-3.1%
-3.1%
1 Year
+5.3%
+5.3%

More News

Read More
News headline image
2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore
April 09, 2026
Via StockStory
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
April 08, 2026
Via StockStory
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗
March 06, 2026
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Reports Mixed Q4 2025 Results with Revenue Beat and Unexpected Loss ↗
February 17, 2026
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation ↗
February 17, 2026
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Growth and Technical Setup ↗
January 29, 2026
Via Chartmill
News headline image
Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks
March 24, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
2 Reasons to Like HALO (and 1 Not So Much)
February 24, 2026
Via StockStory
Topics Stocks
News headline image
Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics Earnings
News headline image
Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales
February 17, 2026
Via StockStory
News headline image
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know
February 13, 2026
Via StockStory
Topics Economy
News headline image
3 Small-Cap Stocks with Solid Fundamentals
February 08, 2026
Via StockStory
Topics Government
News headline image
3 Growth Stocks Set to Flourish
February 01, 2026
Via StockStory
News headline image
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack
January 29, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
January 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
HALO Stock Edges Up 3% On Upbeat Multi-Year Revenue Guidance, Surf Bio Acquisition ↗
January 28, 2026
Via Stocktwits
News headline image
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)
January 27, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
January 25, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
January 24, 2026
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
News headline image
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)
January 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
January 19, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty ↗
January 19, 2026
Via The Motley Fool
News headline image
Q3 Therapeutics Earnings: Halozyme Therapeutics (NASDAQ:HALO) Earns Top Marks
January 18, 2026
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 63.79
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 04/28/26 11:16 AM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.08B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap